MX370184B - Pharmaceutical composition comprising fingolimod. - Google Patents
Pharmaceutical composition comprising fingolimod.Info
- Publication number
- MX370184B MX370184B MX2015015681A MX2015015681A MX370184B MX 370184 B MX370184 B MX 370184B MX 2015015681 A MX2015015681 A MX 2015015681A MX 2015015681 A MX2015015681 A MX 2015015681A MX 370184 B MX370184 B MX 370184B
- Authority
- MX
- Mexico
- Prior art keywords
- fingolimod
- pharmaceutical composition
- capsules
- tablets
- lubricant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a pharmaceutical composition suitable for oral administration of fingolimod, which composition exhibits improved stability and has advantageous properties in making orally administrable final dosage forms such as capsules or tablets. The composition comprises fingolimod or a pharmaceutically acceptable salt or ester thereof, tripotassium citrate and, optionally, a lubricant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2013059807 | 2013-05-13 | ||
PCT/EP2013/072767 WO2013190151A1 (en) | 2013-05-13 | 2013-10-31 | Pharmaceutical composition comprising fingolimod |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015015681A MX2015015681A (en) | 2016-03-15 |
MX370184B true MX370184B (en) | 2019-12-04 |
Family
ID=49517499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015015681A MX370184B (en) | 2013-05-13 | 2013-10-31 | Pharmaceutical composition comprising fingolimod. |
Country Status (3)
Country | Link |
---|---|
ES (1) | ES2770500T3 (en) |
MX (1) | MX370184B (en) |
WO (1) | WO2013190151A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016042493A1 (en) | 2014-09-19 | 2016-03-24 | Aizant Drug Research Pvt. Ltd | Pharmaceutical compositions of fingolimod |
EP3810274A4 (en) * | 2018-06-21 | 2022-03-16 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A combination comprising fingolimod and at least one anti-epileptic agent |
GR1009654B (en) * | 2018-08-31 | 2019-11-18 | Φαρματεν Α.Β.Ε.Ε. | Pharmaceutical composition comprising an immunomodulatory agent and method for the preparation thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20130200A1 (en) * | 2003-04-08 | 2013-03-09 | Novartis Ag | PHARMACEUTICAL COMPOSITION CONTAINING AN S1P RECEPTOR AGONIST AND A SUGAR ALCOHOL |
WO2011131368A2 (en) * | 2010-04-22 | 2011-10-27 | Ratiopharm Gmbh | A method of preparing an oral dosage form comprising fingolimod |
-
2013
- 2013-10-31 ES ES13785853T patent/ES2770500T3/en active Active
- 2013-10-31 MX MX2015015681A patent/MX370184B/en active IP Right Grant
- 2013-10-31 WO PCT/EP2013/072767 patent/WO2013190151A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ES2770500T3 (en) | 2020-07-01 |
MX2015015681A (en) | 2016-03-15 |
WO2013190151A1 (en) | 2013-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ742220A (en) | Pharmaceutical compositions comprising meloxicam | |
SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
EA201690107A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE | |
MX351584B (en) | Aqueous pharmaceutical formulation of tapentadol for oral administration. | |
MX2013014788A (en) | Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]am ino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids. | |
MX2015001917A (en) | Pharmaceutical compositions of memantine. | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
IN2013MU02206A (en) | ||
WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
WO2015125152A3 (en) | Pharmaceutical compositions of asenapine | |
PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
MX2015015681A (en) | Pharmaceutical composition comprising fingolimod. | |
WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
WO2014167579A3 (en) | Stable pharmaceutical compositions of tadalafil | |
GR1008228B (en) | Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof | |
EA201991286A1 (en) | A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN | |
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
IN2014DN07898A (en) | ||
PH12016502540A1 (en) | Pharmaceutical dosage forms | |
WO2013054178A8 (en) | Extended release pharmaceutical compositions containing carmabazepine | |
WO2014141298A3 (en) | Stable pharmaceutical composition of fingolimod | |
ES2422657A1 (en) | Solid cilostazol pharmaceutical composition | |
IN2013MU01330A (en) | ||
MX2016004445A (en) | Stable triflusal powder formulation for oral administration and method of preparation thereof. | |
GR1007907B (en) | Pharmaceutical composition containing a phenocarbamate acetylcholinesterase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |